首页> 外文期刊>Bulletin of University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca: Veterinary Medicin >Feline Hypersomatotropism, an Important Cause for the Failure of Insulin Therapy
【24h】

Feline Hypersomatotropism, an Important Cause for the Failure of Insulin Therapy

机译:猫性趋同性,胰岛素治疗失败的重要原因

获取原文
           

摘要

Introduction: Hypersomathotropism is an important feline endocrinopathy, induced by a pituitary growth hormone secreting adenoma. Up until present, most of the diagnosed acromegalic cats were diagnosed previously with insulin dependent diabetes mellitus. Aims: Hypersomathotropism needs imperative exclusion when dealing with poor blood glucose control and insulin resistance. The present paper describes hypersomathotropism diagnosis protocol in two insulin resistant diabetic felines. Material and methods: Two diabetic domestic short hair cats presenting marked insulin resistance and poor blood glucose control were evaluated. Diagnosis protocol included anamnesis, physical evaluation and general and specific biochemistry analysis. Diagnosis confirmation was obtained on contrast enhanced intracranial MRI and morphopathological examination. Results: Both cases displayed marked insulin resistance with 1.5 IU/kg/administration in the male cat (10.5 IU/administration) and 2.4 I.U./kg/administration in the female cat (12 I.U./administration). On physical examination have been observed a slight inferior prognathia on the female cat, clubbed paws on the male cat, broad facial features and obesity (female: 5kg; male: 7 kg). Repeated blood glucose curves confirmed persistent hyperglycaemia 450 mg/dl (61-124 mg/dl) with different doses of insulin. Specific biochemistry revealed an increased concentration of insulin like growth factor–1 determination 1000 ng/ml (208 – 443 ng/ml), above the cut-off for hypersomathotropism diagnosis. Contrast enhanced MRI revealed an enlarged pituitary gland confirming hypersomathotropism. Haematoxylin eosin examination of the pituitary tissue revealed acidophilic cells consistent with growth hormone producing cells. Conclusions: Systemic manifestations are masked by diabetes mellitus clinical signs leading to a high error degree in diagnostic establishment and administration of highly dangerous doses of insulin. With accurate diagnosis, case management and specific treatment can be applied accordingly and in the favor of patient quality of life.
机译:简介:骨增生是垂体生长激素分泌腺瘤引起的一种重要的猫内分泌病。直到目前,大多数被诊断出的肢端肥大猫先前都被诊断出患有胰岛素依赖型糖尿病。目的:在应对血糖控制不佳和胰岛素抵抗时,必须强制性地将高同型性排除在外。本文介绍了两种胰岛素抵抗性糖尿病猫科动物的增生性诊断方案。材料和方法:对两只表现出明显胰岛素抵抗和血糖控制不佳的糖尿病短毛猫进行了评估。诊断方案包括回忆,物理评估以及一般和特定的生化分析。通过对比增强颅内MRI和形态病理学检查获得诊断证实。结果:两种情况均显示出显着的胰岛素抵抗,雄性猫为1.5 IU / kg /次(10.5 IU /次),雌性猫为2.4 I.U./kg/次(12 I.U./次)。在体格检查中,观察到雌性猫的妊娠率略低,雄性猫的棍状爪,宽广的面部特征和肥胖(女性:5kg;男性:7kg)。重复的血糖曲线证实了使用不同剂量的胰岛素持续的高血糖> 450 mg / dl(61-124 mg / dl)。特定的生物化学表明,胰岛素样生长因子-1测定的浓度增加了,> 1000 ng / ml(208 – 443 ng / ml),超过了过度增生性诊断的临界值。增强的MRI对比显示垂体腺增大,证实了超融合性。垂体组织的苏木伊红检查显示嗜酸细胞与生长激素产生细胞一致。结论:糖尿病的临床症状掩盖了全身表现,导致诊断建立和给予高危险剂量的胰岛素时出现高度错误。通过准确的诊断,可以相应地应用病例管理和特殊治疗,有利于患者的生活质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号